7767 50 Pill - white brown capsule/oblong, 18mm
Generic Name: celecoxib
Pill with imprint 7767 50 is White / Brown, Capsule/Oblong and has been identified as Celebrex 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Celebrex is used in the treatment of Osteoarthritis; Ankylosing Spondylitis; Juvenile Rheumatoid Arthritis; Familial Adenomatous Polyposis; Pain and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celebrex 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 7767 50
Celebrex
- Generic Name
- celecoxib
- Imprint
- 7767 50
- Strength
- 50 mg
- Color
- White / Brown
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cox-2 inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00025-1515 | Pfizer Inc. |
68180-0596 (Discontinued) | Lupin Pharmaceuticals, Inc. |
00378-4065 (Discontinued) | Mylan Pharmaceuticals Inc. |
59762-1515 | Viatris |
00591-2817 (Discontinued) | Watson Pharmaceuticals, Inc. |
Related images for "7767 50"
More about Celebrex (celecoxib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (224)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- Support group
- Drug class: cox-2 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.